Positive Results Unveiled for Targeted CNS Cancer Treatment in Recent Study by Plus Therapeutics
Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company, presented promising outcomes from the...
Vaxxinity Says UB-311 Shows Potential Advancements in Alzheimer’s Treatment
By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said early clinical data demonstrated a trend for slowing...
Analysis: Teradata Tops Second Quarter Estimates – Futurum Group
By Tech Edge Editorial Teradata Corp.’s Q2 2023 revenue hit $462M, surpassing analyst predictions of...
Brilliant Earth Group Sales Climb as Showroom Footprint Expands
By Daniella Parra Brilliant Earth Group, Inc. (Nasdaq: BRLT) said net sales rose 1.3% to...
INTERVIEW: PublicSq. CEO Forecasts Swing to Positive Cash Flow in 2024; Reports 12x Sales Jump in 1H 2023
Newly-listed PSQ Holdings, Inc. (NYSE: PSQH) expects to swing to cash flow positive in 2024;...
INTERVIEW: Dutch Bros Raises Guidance as Profit Doubles, Chooses Christine Barone as Next CEO
Dutch Bros Inc. (NYSE: BROS) posts 103% rise in second-quarter Ebitda Revenue rose 34% in...
Comera Life Sciences Boosts SQore Platform Patents
By Daniella Parra Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), said it enhanced its SQore...
Olaplex Sees New Opportunities After Lowering 2023 Guidance
By Daniella Parra Olaplex Holdings, Inc. (NASDAQ: OLPX) said it was looking forward to new...
The ONE Group Second Quarter Sales Surge on Kona Grill, STK Strength
By Daniella Parra The ONE Group Hospitality, Inc. (Nasdaq: STKS) said consolidated comparable sales increased...
FIGS Second Quarter Net Revenue Climbs 13%
By Daniella Parra FIGS, Inc. (NYSE: FIGS), the lifestyle brand dedicated to the healthcare community,...
© Copyright 2025, ExecEdge